DOP2011000351A - Formas estables de n-(2,6-dimetil-4-morfolin-4-il-fenil)-3,3-dimetil-butiramida - Google Patents

Formas estables de n-(2,6-dimetil-4-morfolin-4-il-fenil)-3,3-dimetil-butiramida

Info

Publication number
DOP2011000351A
DOP2011000351A DO2011000351A DO2011000351A DOP2011000351A DO P2011000351 A DOP2011000351 A DO P2011000351A DO 2011000351 A DO2011000351 A DO 2011000351A DO 2011000351 A DO2011000351 A DO 2011000351A DO P2011000351 A DOP2011000351 A DO P2011000351A
Authority
DO
Dominican Republic
Prior art keywords
dimetil
butiramida
morfolin
fenil
stable forms
Prior art date
Application number
DO2011000351A
Other languages
English (en)
Spanish (es)
Inventor
Svend Treppendahl
Karin Liltorp
Diego Heidi Lopez De
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42237259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DOP2011000351(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of DOP2011000351A publication Critical patent/DOP2011000351A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DO2011000351A 2009-05-11 2011-11-11 Formas estables de n-(2,6-dimetil-4-morfolin-4-il-fenil)-3,3-dimetil-butiramida DOP2011000351A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200900597 2009-05-11

Publications (1)

Publication Number Publication Date
DOP2011000351A true DOP2011000351A (es) 2012-01-31

Family

ID=42237259

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2011000351A DOP2011000351A (es) 2009-05-11 2011-11-11 Formas estables de n-(2,6-dimetil-4-morfolin-4-il-fenil)-3,3-dimetil-butiramida

Country Status (23)

Country Link
EP (1) EP2430008A2 (fr)
JP (1) JP2012526152A (fr)
KR (1) KR20120022934A (fr)
CN (1) CN102459208A (fr)
AR (1) AR076556A1 (fr)
AU (1) AU2010246724B2 (fr)
BR (1) BRPI1013930A2 (fr)
CA (1) CA2761383A1 (fr)
CL (1) CL2011002814A1 (fr)
CO (1) CO6460741A2 (fr)
CR (1) CR20110590A (fr)
DO (1) DOP2011000351A (fr)
EA (1) EA201171381A1 (fr)
GE (1) GEP20146006B (fr)
IL (1) IL216148A0 (fr)
MA (1) MA33351B1 (fr)
MX (1) MX2011011885A (fr)
NZ (1) NZ596738A (fr)
SG (1) SG175968A1 (fr)
TN (1) TN2011000557A1 (fr)
TW (1) TW201041857A (fr)
WO (1) WO2010130260A2 (fr)
ZA (1) ZA201108112B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12508239B2 (en) 2019-08-02 2025-12-30 H. Lundbeck A/S Alcohol derivatives as Kv7 potassium channel openers for use in epilepsy or seizures

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI349666B (en) * 2004-03-12 2011-10-01 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivatives
NZ575652A (en) * 2006-08-23 2011-08-26 Valeant Pharmaceuticals Int Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
CN101790374A (zh) * 2007-08-01 2010-07-28 H.隆德贝克有限公司 Kcnq钾通道开放剂用于减轻多巴胺能系统受到干扰的障碍或病症的症状或治疗这种障碍或病症的用途

Also Published As

Publication number Publication date
AR076556A1 (es) 2011-06-22
AU2010246724B2 (en) 2013-03-21
GEP20146006B (en) 2014-01-10
WO2010130260A3 (fr) 2011-06-16
CA2761383A1 (fr) 2010-11-18
WO2010130260A9 (fr) 2012-10-18
SG175968A1 (en) 2011-12-29
CN102459208A (zh) 2012-05-16
MX2011011885A (es) 2011-12-06
ZA201108112B (en) 2013-01-30
CL2011002814A1 (es) 2012-04-13
AU2010246724A1 (en) 2011-12-08
TW201041857A (en) 2010-12-01
WO2010130260A2 (fr) 2010-11-18
MA33351B1 (fr) 2012-06-01
NZ596738A (en) 2013-04-26
IL216148A0 (en) 2012-01-31
EP2430008A2 (fr) 2012-03-21
KR20120022934A (ko) 2012-03-12
CR20110590A (es) 2012-02-22
EA201171381A1 (ru) 2012-05-30
BRPI1013930A2 (pt) 2019-09-24
JP2012526152A (ja) 2012-10-25
CO6460741A2 (es) 2012-06-15
TN2011000557A1 (en) 2013-05-24

Similar Documents

Publication Publication Date Title
PT3320912T (pt) Imunoterapia à base de indoleamina 2,3-dioxigenase
CR20140448A (es) Metodo para unir partes de metal
BRPI0923325A2 (pt) métodos para usar um composto, e para suprimir a produção deum composto de isocianato livre.
DK2049464T3 (da) Fremstilling af 3-[(1R,2R)-3-(dimethylamino)-1ethyl-2-methylpropyl]phenol
LT3210965T (lt) (1r,2r)-3-(3-dimetilamino-1-etil-2-metil-propil)-fenolio gamybos būdas
BRPI1014691A2 (pt) Composto, e, processo para a preparação de um composto.
AR061311A1 (es) Procesos para preparar clorhidrato de cinacalcet y formas polimorficas del mismo
CL2012002082A1 (es) Proceso para la preparacion de lacosamida, por hidroximetilación; compuestos intermediarios.
EA201000258A1 (ru) Новые гербициды
EA201490761A1 (ru) R(+)-n-формилпропаргиламиноиндан
CL2009001363S1 (es) Pieza para maquina de afeitar.
CR20110208A (es) Proceso para la preparación de benzonorbornenos
ECSP13012914A (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea
FR2973475B1 (fr) Module d'eclairage, a homogeneite d'eclairage amelioree.
IT1394243B1 (it) Anello di tenuta
BR112012002130A2 (pt) processo para a preparação de composto,e, composto intermediário
BRPI0922064A2 (pt) processo para preparar uma amida secundaria.
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
BRPI0814581A2 (pt) processo para a preparação de um composto, e, composto.
BRPI0819653A2 (pt) Método para a produção de um composto de tetrapirrol, e, composto de tetrapirrol.
CR20110590A (es) Formas estables de n-(2,6-dimetil-4-morfolin-4-il-fenil)3,3- dimetil-butiramida
BRPI0816869A2 (pt) Processo para a preparação de 4-aminobut-2-enolidas.
FI20086106L (fi) Nastarenkaan nasta
NO20083730L (no) Fremgangsmate for fremstilling av entakapon
FI20055676L (fi) Nastarenkaan nasta